Enhancing bone marrow regeneration by SALL4 protein

Journal of Hematology and Oncology

Volumn 6, Issue 1, 2013, Pages

  Liao, Wenbin ^a   Aguila, Jerell R ^a   Yao, Yixin ^b   Yang, Jianchang ^a   Zieve, Gary ^a   Jiang, Yongping ^d   Avila, Cecilia ^a   Senzel, Lisa ^a   Lai, Raymond ^c   Xu, Dazhong ^b   Dai, Wei ^b   Ma, Yupo ^a  

^a STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

^d PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Bone marrow transplantation; Hematopoietic stem cell; Recombinant protein; Regeneration; SALL4

Indexed keywords

HYBRID PROTEIN; RECOMBINANT PROTEIN; TAT SALL4B PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW REGENERATION; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DEATH; DONOR; ENGRAFTMENT; FLOW CYTOMETRY; GRAFT RECIPIENT; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; IRRADIATION; MOUSE; NONHUMAN; QUANTITATIVE ANALYSIS; REGENERATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL EXPANSION; UMBILICAL CORD BLOOD;

ANIMALS; BONE MARROW; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; MCF-7 CELLS; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, SCID; REGENERATION; SF9 CELLS; TRANSCRIPTION FACTORS;

EID: 84887090667     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/1756-8722-6-84     Document Type: Article

References (35)

1. HLA-matched sibling transplantation with G-CSF mobilized PBSCs and BM decreases GVHD in adult patients with severe aplastic anemia. Sun ZM, Liu HL, Geng LQ, Wang XB, Yao W, Liu X, Ding KY, Han YS, Yang HZ, Tang BL, et al. J Hematol Oncol 2010 3 51 10.1186/1756-8722-3-51 21194460
2. Cord blood banking: a historical perspective. Navarrete C, Contreras M, Br J Haematol 2009 147 236 245 10.1111/j.1365-2141.2009.07827.x 19796273
3. Endocrinological problems in malformation of the male genitalia. Glatzl J, Prog Pediatr Surg 1984 17 1 10
4. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C, Goldman A, Kersey J, Krivit W, MacMillan ML, et al. Blood 2002 100 1611 1618 12176879 (Pubitemid 34925136)
5. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. Laughlin MJ, Barker J, Bambach B, Koc ON, Rizzieri DA, Wagner JE, Gerson SL, Lazarus HM, Cairo M, Stevens CE, et al. N Engl J Med 2001 344 1815 1822 10.1056/NEJM200106143442402 11407342 (Pubitemid 32538694)
6. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. Gluckman E, Rocha V, Boyer-Chammard A, Locatelli F, Arcese W, Pasquini R, Ortega J, Souillet G, Ferreira E, Laporte JP, et al. N Engl J Med 1997 337 373 381 10.1056/NEJM199708073370602 9241126 (Pubitemid 27328367)
7. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, McGlave PB, Miller JS, Verfaillie CM, Wagner JE, Blood 2005 105 1343 1347 15466923 (Pubitemid 40170912)
8. Double unrelated reduced-intensity umbilical cord blood transplantation in adults. Ballen KK, Spitzer TR, Yeap BY, McAfee S, Dey BR, Attar E, Haspel R, Kao G, Liney D, Alyea E, et al. Biol Blood Marrow Transplant 2007 13 82 89 17222756 (Pubitemid 46044092)
9. Double cord blood transplantation: extending the use of unrelated umbilical cord blood cells for patients with hematological diseases. Rocha V, Crotta A, Ruggeri A, Purtill D, Boudjedir K, Herr AL, Ionescu I, Gluckman E, Eurocord R, Best practice res Clin haematol 2010 23 223 229 10.1016/j.beha.2010. 07.005
10. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Brunstein CG, Barker JN, Weisdorf DJ, DeFor TE, Miller JS, Blazar BR, McGlave PB, Wagner JE, Blood 2007 110 3064 3070 10.1182/blood-2007-04-067215 17569820 (Pubitemid 350006962)
11. Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. Delaney C, Heimfeld S, Brashem-Stein C, Voorhies H, Manger RL, Bernstein ID, Nat Med 2010 16 232 236 10.1038/nm.2080 20081862
12. Differential effects of HOXB4 on nonhuman primate short- and long-term repopulating cells. Zhang XB, Beard BC, Beebe K, Storer B, Humphries RK, Kiem HP, PLoS Med 2006 3 173 10.1371/journal.pmed.0030173 16637742
13. Expansion of hematopoietic stem cells for transplantation: current perspectives. Schuster JA, Stupnikov MR, Ma G, Liao W, Lai R, Ma Y, Aguila JR, Exp Hematol Oncol 2012 1 12 10.1186/2162-3619-1-12 23210618
14. CD133: a stem cell biomarker and beyond. Li Z, Exp Hematol Oncol 2013 2 17 10.1186/2162-3619-2-17 23815814
15. Ex vivo expansion of human hematopoietic stem and progenitor cells. Dahlberg A, Delaney C, Bernstein ID, Blood 2011 117 6083 6090 10.1182/blood-2011-01-283606 21436068
16. SALL4 is a robust stimulator for the expansion of hematopoietic stem cells. Aguila JR, Liao WB, Yang JC, Avila C, Hagag N, Senzel L, Ma YP, Blood 2011 118 576 585 10.1182/blood-2011-01-333641 21602528
17. Enhanced self-renewal of hematopoietic stem/progenitor cells mediated by the stem cell gene Sall4. Yang J, Aguila JR, Alipio Z, Lai R, Fink LM, Ma Y, J Hematol Oncol 2011 4 38 10.1186/1756-8722-4-38 21943195
18. SALL4: finally an answer to the problem of expansion of hematopoietic stem cells? Aguila JR, Mynarcik DC, Ma Y, Expert Rev Hematol 2011 4 479 481 10.1586/ehm.11.46 21939414
19. Genome-wide analysis reveals Sall4 to be a major regulator of pluripotency in murine-embryonic stem cells. Yang J, Chai L, Fowles TC, Alipio Z, Xu D, Fink LM, Ward DC, Ma Y, Proc Natl Acad Sci U S A 2008 105 19756 19761 10.1073/pnas.0809321105 19060217
20. A novel SALL4/OCT4 transcriptional feedback network for pluripotency of embryonic stem cells. Yang J, Gao C, Chai L, Ma Y, PLoS One 2010 5 10766 10.1371/journal.pone.0010766 20505821
21. Dissecting the role of SALL4, a newly identified stem cell factor, in chronic myelogenous leukemia. Lu J, Ma Y, Kong N, Alipio Z, Gao C, Krause DS, Silberstein LE, Chai L, Leukemia 2011 25 1211 1213 10.1038/leu.2011.65 21468036
22. Pleiotrophin regulates the expansion and regeneration of hematopoietic stem cells. Himburg HA, Muramoto GG, Daher P, Meadows SK, Russell JL, Doan P, Chi JT, Salter AB, Lento WE, Reya T, et al. Nat Med 2010 16 475 482 10.1038/nm.2119 20305662
23. In vivo radioprotective effects of recombinant human granulocyte colony-stimulating factor in lethally irradiated mice. Uckun FM, Souza L, Waddick KG, Wick M, Song CW, Blood 1990 75 638 645 1688721 (Pubitemid 20069203)
24. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor gamma chain(null) mice. Ishikawa F, Yasukawa M, Lyons B, Yoshida S, Miyamoto T, Yoshimoto G, Watanabe T, Akashi K, Shultz LD, Harada M, Blood 2005 106 1565 1573 10.1182/blood-2005-02-0516 15920010 (Pubitemid 41208567)
25. Stem cell gene SALL4 suppresses transcription through recruitment of DNA methyltransferases. Yang J, Corsello TR, Ma Y, J Biol Chem 2012 287 1996 2005 10.1074/jbc.M111.308734 22128185
26. In vitro expansion of hematopoietic stem cells by recombinant TAT-HOXB4 protein. Krosl J, Austin P, Beslu N, Kroon E, Humphries RK, Sauvageau G, Nat Med 2003 9 1428 1432 10.1038/nm951 14578881 (Pubitemid 37466195)
27. Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling. Varnum-Finney B, Xu L, Brashem-Stein C, Nourigat C, Flowers D, Bakkour S, Pear WS, Bernstein ID, Nat Med 2000 6 1278 1281 10.1038/81390 11062542
28. TAT-mediated transduction of NF-Ya peptide induces the ex vivo proliferation and engraftment potential of human hematopoietic progenitor cells. Domashenko AD, Danet Desnoyers G, Aron A, Carroll MP, Emerson SG, Blood 2010 116 2676 2683 10.1182/blood-2010-03-273441 20616221
29. SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice. Ma Y, Cui W, Yang J, Qu J, Di C, Amin HM, Lai R, Ritz J, Krause DS, Chai L, Blood 2006 108 2726 2735 10.1182/blood-2006-02-001594 16763212
30. Transcriptional regulatory networks in embryonic stem cells. Chan YS, Yang L, Ng HH, Prog Drug Res 2011 67 239 252 21141733
31. Sall4 interacts with Nanog and co-occupies Nanog genomic sites in embryonic stem cells. Wu Q, Chen X, Zhang J, Loh YH, Low TY, Zhang W, Sze SK, Lim B, Ng HH, J Biol Chem 2006 281 24090 24094 10.1074/jbc.C600122200 16840789 (Pubitemid 44274183)
32. Functional antagonism between Sall4 and Plzf defines germline progenitors. Hobbs RM, Fagoonee S, Papa A, Webster K, Altruda F, Nishinakamura R, Chai L, Pandolfi PP, Cell Stem Cell 2012 10 284 298 10.1016/j.stem.2012.02. 004 22385656
33. Heterogeneous populations of bone marrow stem cells-are we spotting on the same cells from the different angles? Ratajczak MZ, Kucia M, Majka M, Reca R, Ratajczak J, Folia Histochem Cytobiol 2004 42 139 146 15493574 (Pubitemid 39144950)
34. Pluripotent and multipotent stem cells in adult tissues. Ratajczak MZ, Zuba-Surma E, Kucia M, Poniewierska A, Suszynska M, Ratajczak J, Adv Med Sci 2012 57 1 17 22515973
35. Endothelial and perivascular cells maintain haematopoietic stem cells. Ding L, Saunders TL, Enikolopov G, Morrison SJ, Nature 2012 481 457 462 10.1038/nature10783 22281595